Clinical efficacy analysis of furmonertinib and structural insights into sensitivity to diverse TKIs for NSCLC with EGFR exon 20 insertion.

Xiao Zhang(Zhengzhou University), Hong Tang(First Affiliated Hospital of Jiangxi Medical College), Yanfang Yang(Peking University), Huijuan Wang(Beijing Chao-Yang Hospital, Capital Medical University), Saijun Fan(Chinese Academy of Medical Sciences & Peking Union Medical College), Guoxing Feng(Chinese Academy of Medical Sciences & Peking Union Medical College), Hui Zhu(Sun Yat-sen University), Huan Han(Zhengzhou University), Baoxing Liu(Henan Cancer Hospital), Bosheng Dong
Journal of Clinical Oncology
June 1, 2023
Cited by 0


Related Papers